Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1
Journal article published in 2020 by
Amy E. Armstrong 
,
Steven D. Rhodes,
Abbi Smith,
Shi Chen,
Waylan Bessler,
Michael J. Ferguson,
Li Jiang,
Xiaohong Li,
Jin Yuan,
Xianlin Yang,
Feng‐Chun Yang,
Kent A. Robertson,
David A. Ingram,
Jaishri O. Blakeley,
D. Wade Clapp
,
Steven D. Rhodes,
Abbi Smith,
Shi Chen,
Waylan Bessler,
Michael J. Ferguson,
Li Jiang,
Xiaohong Li,
Jin Yuan,
Xianlin Yang,
Feng‐Chun Yang,
Kent A. Robertson,
David A. Ingram,
Jaishri O. Blakeley,
D. Wade Clapp
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 